• Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, 100191, P.R.China;
ZHAO Yiming, Email: yimingzhao115@163.com
Export PDF Favorites Scan Get Citation

The level of evidence in randomized controlled studies is high. However, it cannot be widely applied due to its high cost, external authenticity, ethics and other reasons. The traditional observational studies reduce the internal authenticity due to various confounding factors, and the level of evidence is low. Regression discontinuity design (RDD) is a design that observes and compares outcome of object around the threshold under practical clinical conditions. Its capability to adjust confounding factors is second only to that of randomized control studies. It can be used in cases where the intervention (or exposure) is directly related to the value of a continuous variable. For instance, whether an HIV patient needs antiretroviral treatment mainly depends on whether the CD4 cell count is lower than 200/μL. Because the measurement of continuous variables has random error, whether intervention is given near the threshold or is close to random, the baseline of patients in the intervention group and non-intervention group near the threshold should be balanced and comparable. Based on this assumption, the causal effect of intervention (or exposure) and outcome can be estimated by comparing the outcomes of populations near the threshold. RDD is mainly applicable to the study of classification outcomes in medicine, among which two-stage least square method, likelihood ratio based estimation method and Bayesian method are more commonly used model estimation methods. However, the application conditions of RDD and the requirement of sample size limit its extensive application in medicine. With the improvement of data accessibility and the development of real world research, RDD will be more widely used in clinical research.

Citation: ZHANG Hua, WANG Xiaoxiao, ZENG Lin, LI Nan, TAO Liyuan, SHI Yanyan, CHU Hongling, NI Kaiwen, ZHAO Yiming. The application of regression discontinuity design in clinical therapeutic research. Chinese Journal of Evidence-Based Medicine, 2018, 18(11): 1207-1211. doi: 10.7507/1672-2531.201807146 Copy

  • Previous Article

    The application of mixed methods research in real world studies
  • Next Article

    Causes and countermeasures of waste in clinical research of Chinese medicine